United Kingdom · Series A startup

Who invested in Complement Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$79Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $79MApr 2023
Investors
1
See who backed them

The rounds

  1. Apr 2023
    Series A$79M

    Source recorded

Everyone who backed them

Forbion Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Complement Therapeutics

Who invested in Complement Therapeutics?

Complement Therapeutics's investors include Forbion Capital Partners.

How much has Complement Therapeutics raised?

Complement Therapeutics has raised $79M across 1 round since 2023.

When did Complement Therapeutics last raise?

Complement Therapeutics's most recent round was a Series A of $79M in Apr 2023.

What was Complement Therapeutics's biggest round?

Its most recent round, $79M in Apr 2023, is also its largest on record.

Who backed Complement Therapeutics first?

Complement Therapeutics's first round on record, in Apr 2023, was backed by Forbion Capital Partners.

What stage is Complement Therapeutics at?

Complement Therapeutics's latest named round is a Series A, in Apr 2023.

Where is Complement Therapeutics based?

Complement Therapeutics is based in the United Kingdom.

Companies like Complement Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.